Home Maxim Group Cuts Cytori Therapeutics Price Target to $5.00
 

Keywords :   


Maxim Group Cuts Cytori Therapeutics Price Target to $5.00

2015-08-09 03:47:14| Biotech - Topix.net

Separately, Roth Capital restated a "buy" rating and issued a $6.00 target price on shares of Cytori Therapeutics in a research note on Tuesday, June 16th. Shares of Cytori Therapeutics traded up 2.5122% during midday trading on Friday, reaching $0.4203.

Tags: price group target cuts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
18.05This Week in Agribusiness, May 18, 2024
18.05This Week in Agribusiness, May 18, 2024
More »